<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308197">
  <stage>Registered</stage>
  <submitdate>25/08/2009</submitdate>
  <approvaldate>26/08/2009</approvaldate>
  <actrnumber>ACTRN12609000743268</actrnumber>
  <trial_identification>
    <studytitle>The absorption of fentanyl from a new wafer in patients who have had major surgery</studytitle>
    <scientifictitle>The pharmacokinetics and acceptability of a sublingual fentanyl wafer in postoperative patients who have had major gynaecological surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A single administration of sublingual fentanyl wafer 50 mcg and single administration of intravenous fentanyl 50 mcg, in randomised order, with an 18 hour washout period, after major gynaecological surgery among patients having patient-controlled intavenous morphine</interventions>
    <comparator>A single control administration of intravenous fentanyl 50 mcg, in randomised order with sublingual fentanyl, with an 18 hour washout period, after major gynaecological surgery among patients having patient-controlled intavenous morphine</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Drug pharmacokinetics based on fentanyl assay in venous blood using Gas Chromatography Mass Spectrometry (GCMS)</outcome>
      <timepoint>2,5,10,30,60,120, and 180 minutes post-administration for each route of administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient acceptability of wafer assessed by questionnaire and verbal numerical rating score 0-10</outcome>
      <timepoint>Assessed at 30 minutes post-administration</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age 18-70 years
Gynaecological surgery
Using intravenous morphine patient -controlled analgesia postoperatively</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Oral pathology
Intolerance of opioids
Pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Preoperative written consent then allocated using sealed envelope according to cross-over randomization sequence</concealment>
    <sequence>Latin square randomisation for cross-over sequence</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/10/2009</anticipatedstartdate>
    <actualstartdate>25/11/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>16/11/2010</actualenddate>
    <samplesize>25</samplesize>
    <actualsamplesize>21</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>King Edward Memorial Hospital for Women</primarysponsorname>
    <primarysponsoraddress>374 Bagot Rd
Subiaco WA 6008</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>iX Biopharma</fundingname>
      <fundingaddress>Vbox 881705
Singapore 919191</fundingaddress>
      <fundingcountry>Singapore</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The pharmacokinetics of a new formulation of fentanyl citrate are being evaluated in postoperative patients</summary>
    <trialwebsite />
    <publication>Lim CB, Paech MJ, Sunderland B, Liu Y. In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation. Drug Res Develop Ther 2013;7:317-24</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Women's and Newborn's Health Service</ethicname>
      <ethicaddress />
      <ethicapprovaldate>7/07/2009</ethicapprovaldate>
      <hrec>1700/EW</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Chin Beng (Stephen) Lim</name>
      <address>Pharmacy Department
PO Box 460
Armadale
6992</address>
      <phone>+61 8 93343722</phone>
      <fax />
      <email>Stephen.Lim@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Chin Beng (Stephen) Lim</name>
      <address>Pharmacy Department
PO Box 460
Armadale
6992</address>
      <phone>+61 8 93343722</phone>
      <fax />
      <email>Stephen.Lim@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot rd
Subiaco WA 6008</address>
      <phone>+61 414930438</phone>
      <fax>+61 8 93402260</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Chin Beng (Stephen) Lim </name>
      <address>Pharmacy Department, PO Box 460 Armadale 6992 Western Australia, Australia</address>
      <phone>+61 8 93343722</phone>
      <fax />
      <email>Stephen.Lim@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>